Sign Out
Liver disease: Clomifene Citrate (Ova-Mit) therapy is contraindicated in patients with liver disease or a history of liver dysfunction.
Abnormal uterine bleeding: Clomifene Citrate (Ova-Mit) is contraindicated in patients with hormone-dependent tumours or in patient with abnormal uterine bleeding of undetermined origin.
Ovarian cyst: Clomifene Citarte (Ova-Mit) tablets should not be given in the presence of an ovarian cyst, except polycystic ovary, since further enlargement of the cyst may occur. Patients should be evaluated for the presence of the ovarian cyst prior to each course of treatment.
Continue with Google